20-17988280-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_052865.4(MGME1):​c.846T>C​(p.Asp282Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.3 in 1,613,072 control chromosomes in the GnomAD database, including 74,532 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6220 hom., cov: 32)
Exomes 𝑓: 0.30 ( 68312 hom. )

Consequence

MGME1
NM_052865.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.00900

Publications

20 publications found
Variant links:
Genes affected
MGME1 (HGNC:16205): (mitochondrial genome maintenance exonuclease 1) The protein encoded by this gene is a nuclear-encoded mitochondrial protein necessary for the maintenance of mitochondrial genome synthesis. The encoded protein is a RecB-type exonuclease and primarily cleaves single-stranded DNA. Defects in this gene have been associated with mitochondrial DNA depletion syndrome-11. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2015]
OVOL2 (HGNC:15804): (ovo like zinc finger 2) This gene encodes a member of the evolutionarily conserved ovo-like protein family. Mammalian members of this family contain a single zinc finger domain composed of a tetrad of C2H2 zinc fingers with variable N- and C-terminal extensions that contain intrinsically disordered domains. Members of this family are involved in epithelial development and differentiation. Knockout of this gene in mouse results in early embryonic lethality with phenotypes that include neurectoderm expansion, impaired vascularization, and heart anomalies. In humans, allelic variants of this gene have been associated with posterior polymorphous corneal dystrophy. [provided by RefSeq, Apr 2016]
OVOL2 Gene-Disease associations (from GenCC):
  • posterior polymorphous corneal dystrophy 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • congenital hereditary endothelial dystrophy type I
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • posterior polymorphous corneal dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 20-17988280-T-C is Benign according to our data. Variant chr20-17988280-T-C is described in ClinVar as Benign. ClinVar VariationId is 262249.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.009 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.417 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MGME1NM_052865.4 linkc.846T>C p.Asp282Asp synonymous_variant Exon 4 of 5 ENST00000377710.10 NP_443097.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MGME1ENST00000377710.10 linkc.846T>C p.Asp282Asp synonymous_variant Exon 4 of 5 1 NM_052865.4 ENSP00000366939.5

Frequencies

GnomAD3 genomes
AF:
0.280
AC:
42620
AN:
152022
Hom.:
6212
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.213
Gnomad AMI
AF:
0.347
Gnomad AMR
AF:
0.269
Gnomad ASJ
AF:
0.331
Gnomad EAS
AF:
0.433
Gnomad SAS
AF:
0.424
Gnomad FIN
AF:
0.339
Gnomad MID
AF:
0.206
Gnomad NFE
AF:
0.290
Gnomad OTH
AF:
0.266
GnomAD2 exomes
AF:
0.312
AC:
78102
AN:
250724
AF XY:
0.318
show subpopulations
Gnomad AFR exome
AF:
0.212
Gnomad AMR exome
AF:
0.229
Gnomad ASJ exome
AF:
0.334
Gnomad EAS exome
AF:
0.443
Gnomad FIN exome
AF:
0.342
Gnomad NFE exome
AF:
0.294
Gnomad OTH exome
AF:
0.288
GnomAD4 exome
AF:
0.302
AC:
440913
AN:
1460932
Hom.:
68312
Cov.:
34
AF XY:
0.305
AC XY:
221940
AN XY:
726776
show subpopulations
African (AFR)
AF:
0.206
AC:
6893
AN:
33438
American (AMR)
AF:
0.233
AC:
10400
AN:
44638
Ashkenazi Jewish (ASJ)
AF:
0.336
AC:
8774
AN:
26110
East Asian (EAS)
AF:
0.393
AC:
15598
AN:
39648
South Asian (SAS)
AF:
0.410
AC:
35304
AN:
86110
European-Finnish (FIN)
AF:
0.340
AC:
18162
AN:
53410
Middle Eastern (MID)
AF:
0.219
AC:
1264
AN:
5766
European-Non Finnish (NFE)
AF:
0.294
AC:
326290
AN:
1111460
Other (OTH)
AF:
0.302
AC:
18228
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
14158
28315
42473
56630
70788
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10936
21872
32808
43744
54680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.280
AC:
42647
AN:
152140
Hom.:
6220
Cov.:
32
AF XY:
0.288
AC XY:
21389
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.213
AC:
8834
AN:
41496
American (AMR)
AF:
0.269
AC:
4103
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.331
AC:
1150
AN:
3470
East Asian (EAS)
AF:
0.432
AC:
2235
AN:
5170
South Asian (SAS)
AF:
0.424
AC:
2046
AN:
4828
European-Finnish (FIN)
AF:
0.339
AC:
3592
AN:
10602
Middle Eastern (MID)
AF:
0.214
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
0.290
AC:
19750
AN:
67996
Other (OTH)
AF:
0.266
AC:
560
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1579
3158
4736
6315
7894
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
438
876
1314
1752
2190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.264
Hom.:
3525
Bravo
AF:
0.267
Asia WGS
AF:
0.412
AC:
1433
AN:
3478
EpiCase
AF:
0.280
EpiControl
AF:
0.277

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 19, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:2
Feb 23, 2016
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 02, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
0.62
DANN
Benign
0.76
PhyloP100
-0.0090
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28455091; hg19: chr20-17968923; COSMIC: COSV66624245; API